{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:34:45Z","timestamp":1776659685539,"version":"3.51.2"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6880","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1038\/416507a","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T04:31:14Z","timestamp":1027657874000},"page":"507-511","source":"Crossref","is-referenced-by-count":2135,"title":["Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases"],"prefix":"10.1038","volume":"416","author":[{"given":"Monica","family":"Bucciantini","sequence":"first","affiliation":[]},{"given":"Elisa","family":"Giannoni","sequence":"additional","affiliation":[]},{"given":"Fabrizio","family":"Chiti","sequence":"additional","affiliation":[]},{"given":"Fabiana","family":"Baroni","sequence":"additional","affiliation":[]},{"given":"Lucia","family":"Formigli","sequence":"additional","affiliation":[]},{"given":"Jes\u00fas","family":"Zurdo","sequence":"additional","affiliation":[]},{"given":"Niccol\u00f2","family":"Taddei","sequence":"additional","affiliation":[]},{"given":"Giampietro","family":"Ramponi","sequence":"additional","affiliation":[]},{"given":"Christopher M.","family":"Dobson","sequence":"additional","affiliation":[]},{"given":"Massimo","family":"Stefani","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BF416507a_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0959-440X(98)80016-X","volume":"8","author":"JW Kelly","year":"1998","unstructured":"Kelly, J. W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8, 101\u2013106 (1998).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"BF416507a_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1098\/rstb.2000.0758","volume":"356","author":"CM Dobson","year":"2001","unstructured":"Dobson, C. M. The structural basis of protein folding and its links with human disease. Phil. Trans. R. Soc. Lond. B 356, 133\u2013145 (2001).","journal-title":"Phil. Trans. R. Soc. Lond. B"},{"key":"BF416507a_CR3","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","volume":"95","author":"MP Lambert","year":"1998","unstructured":"Lambert, M. P. et al. Diffusible, nonfibrillar ligands derived from A\u03b2-42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 6448\u20136453 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF416507a_CR4","doi-asserted-by":"publisher","first-page":"8876","DOI":"10.1523\/JNEUROSCI.19-20-08876.1999","volume":"19","author":"DM Hartley","year":"1999","unstructured":"Hartley, D. M. et al. Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19, 8876\u20138884 (1999).","journal-title":"J. Neurosci."},{"key":"BF416507a_CR5","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1046\/j.1471-4159.1999.0731626.x","volume":"73","author":"T Pillot","year":"1999","unstructured":"Pillot, T. et al. The nonfibrillar amyloid \u03b2-peptide induces apoptotic neuronal cell death: involvement of its C-terminal fusogenic domain. J. Neurochem. 73, 1626\u20131634 (1999).","journal-title":"J. Neurochem."},{"key":"BF416507a_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0304-3940(99)00899-X","volume":"278","author":"A Monji","year":"2000","unstructured":"Monji, A. et al. Inhibition of A\u03b2 fibril formation and A\u03b2-induced cytotoxicity by senile plaque-associated proteins. Neurosci. Lett. 278, 81\u201384 (2000).","journal-title":"Neurosci. Lett."},{"key":"BF416507a_CR7","doi-asserted-by":"publisher","first-page":"25945","DOI":"10.1074\/jbc.274.36.25945","volume":"274","author":"DM Walsh","year":"1999","unstructured":"Walsh, D. M. et al. Amyloid \u03b2-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274, 25945\u201325952 (1999).","journal-title":"J. Biol. Chem."},{"key":"BF416507a_CR8","doi-asserted-by":"publisher","first-page":"E115","DOI":"10.1038\/35017124","volume":"2","author":"MS Goldberg","year":"2000","unstructured":"Goldberg, M. S. & Lansbury, P. T. Jr Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease? Nature Cell. Biol. 2, E115\u2013E119 (2000).","journal-title":"Nature Cell. Biol."},{"key":"BF416507a_CR9","doi-asserted-by":"publisher","first-page":"571\u2014576","DOI":"10.1073\/pnas.97.2.571","volume":"97","author":"KA Conway","year":"2000","unstructured":"Conway, K. A. et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl Acad. Sci. USA 97, 571\u2014576 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF416507a_CR10","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1096\/fasebj.14.9.1244","volume":"14","author":"YJ Zhu","year":"2000","unstructured":"Zhu, Y. J., Lin, H. & Lal, R. Fresh and nonfibrillar amyloid beta protein(1\u201340) induces rapid cellular degeneration in aged human fibroblasts: evidence for A beta P-channel-mediated cellular toxicity. FASEB J. 14, 1244\u20131254 (2000).","journal-title":"FASEB J."},{"key":"BF416507a_CR11","first-page":"1512","volume-title":"Oxford Textbook of Medicine","author":"MB Pepys","year":"1995","unstructured":"Pepys, M. B. in Oxford Textbook of Medicine (eds Weatherall, D. J., Ledingham, J. G. & Warrel, D. A.) 3rd edn, 1512\u20131524 (Oxford Univ. Press, Oxford, 1995)."},{"key":"BF416507a_CR12","doi-asserted-by":"publisher","first-page":"12243","DOI":"10.1073\/pnas.91.25.12243","volume":"91","author":"A Lorenzo","year":"1994","unstructured":"Lorenzo, A. & Yankner, B. A. \u03b2-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl Acad. Sci. USA 91, 12243\u201312247 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF416507a_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/380168a0","volume":"380","author":"T Thomas","year":"1996","unstructured":"Thomas, T., Thomas, G., McLendon, C., Sutton, T. & Mullan, M. \u03b2-Amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380, 168\u2013171 (1996).","journal-title":"Nature"},{"key":"BF416507a_CR14","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/35018098","volume":"406","author":"G Clarke","year":"2000","unstructured":"Clarke, G. et al. A one-hit model of cell death in inherited neuronal degenerations. Nature 406, 195\u2013199 (2000).","journal-title":"Nature"},{"key":"BF416507a_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/35084141","volume":"412","author":"MF Perutz","year":"2001","unstructured":"Perutz, M. F. & Windle, A. H. Cause of neuronal death in neurodegenerative disease attributable to expansion of glutamine repeats. Nature 412, 143\u2013144 (2001).","journal-title":"Nature"},{"key":"BF416507a_CR16","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1177\/22.12.1141","volume":"22","author":"GG Glenner","year":"1974","unstructured":"Glenner, G. G., Eanes, E. D., Bladen, H. A., Linke, R. P. & Termine, J. D. Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J. Histochem. Cytochem. 22, 1141\u20131158 (1974).","journal-title":"J. Histochem. Cytochem."},{"key":"BF416507a_CR17","doi-asserted-by":"publisher","first-page":"4224","DOI":"10.1073\/pnas.95.8.4224","volume":"95","author":"JI Guijarro","year":"1998","unstructured":"Guijarro, J. I., Sunde, M., Jones, J. A., Campbell, I. D. & Dobson, C. M. Amyloid fibril formation by an SH3 domain. Proc. Natl Acad. Sci. USA 95, 4224\u20134228 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF416507a_CR18","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1073\/pnas.96.7.3590","volume":"96","author":"F Chiti","year":"1999","unstructured":"Chiti, F. et al. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl Acad. Sci. USA 96, 3590\u20133594 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF416507a_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/35065514","volume":"410","author":"M Fandrich","year":"2001","unstructured":"Fandrich, M., Fletcher, M. A. & Dobson, C. M. Amyloid fibrils from muscle myoglobin. Nature 410, 165\u2013166 (2001).","journal-title":"Nature"},{"key":"BF416507a_CR20","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1110\/ps.ps.10201","volume":"10","author":"F Chiti","year":"2001","unstructured":"Chiti, F. et al. Solution conditions can promote formation of either amyloid protofilaments or mature fibrils from the HypF N-terminal domain. Protein Sci. 10, 2541\u20132547 (2001).","journal-title":"Protein Sci."},{"key":"BF416507a_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0065-3233(08)60320-4","volume":"50","author":"M Sunde","year":"1997","unstructured":"Sunde, M. & Blake, C. F. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem. 50, 123\u2013159 (1997).","journal-title":"Adv. Protein Chem."},{"key":"BF416507a_CR22","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/emboj\/18.4.815","volume":"18","author":"JL Jimenez","year":"1999","unstructured":"Jimenez, J. L. et al. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 18, 815\u2013821 (1999).","journal-title":"EMBO J."},{"key":"BF416507a_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1046\/j.1471-4159.1997.69020581.x","volume":"69","author":"Y Liu","year":"1997","unstructured":"Liu, Y., Peterson, D. A., Kimura, H. & Schubert, D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 69, 581\u2013593 (1997).","journal-title":"J. Neurochem."},{"key":"BF416507a_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0168-0102(98)00055-8","volume":"31","author":"K Abe","year":"1998","unstructured":"Abe, K. & Saito, H. Amyloid beta protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes. Neurosci. Res. 31, 295\u2013305 (1998).","journal-title":"Neurosci. Res."},{"key":"BF416507a_CR25","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S1074-5521(97)90303-3","volume":"4","author":"JD Harper","year":"1997","unstructured":"Harper, J. D., Lieber, C. M. & Lansbury, P. T. Jr Atomic force microscopy imaging of seeded fibril formation and fibril branching by Alzheimer's disease amyloid-\u03b2 protein. Chem. Biol. 4, 951\u2013959 (1997).","journal-title":"Chem. Biol."},{"key":"BF416507a_CR26","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/S0002-9440(10)63050-7","volume":"159","author":"M Mendes Sousa","year":"2001","unstructured":"Mendes Sousa, M., Cardoso, I., Fernandes, R., Guimaraes, A. & Saraiva, M. J. Deposition of transthyretin in early stages of familial amylodotic polyneuropathy. Evidence for toxicity of nonfibrillar aggregates. Am. J. Pathol. 159, 1993\u20132000 (2001).","journal-title":"Am. J. Pathol."},{"key":"BF416507a_CR27","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/81937","volume":"7","author":"Y Fezoui","year":"2000","unstructured":"Fezoui, Y. et al. A de novo designed helix-turn-helix peptide forms non-toxic amyloid fibrils. Nature Struct. Biol. 7, 1095\u20131099 (2000).","journal-title":"Nature Struct. Biol."},{"key":"BF416507a_CR28","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","volume":"96","author":"AY Hsia","year":"1999","unstructured":"Hsia, A. Y. et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl Acad. Sci. USA 96, 3228\u20133233 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BF416507a_CR29","doi-asserted-by":"publisher","first-page":"8141","DOI":"10.1021\/ja016229b","volume":"123","author":"J Zurdo","year":"2001","unstructured":"Zurdo, J., Guijarro, J. I. & Dobson, C. M. Preparation and characterisation of purified amyloid fibrils. J. Am. Chem. Soc. 123, 8141\u20138142 (2001).","journal-title":"J. Am. Chem. Soc."},{"key":"BF416507a_CR30","first-page":"364","volume-title":"Mechanisms of Protein Folding","author":"MR Leroux","year":"1999","unstructured":"Leroux, M. R. & Hartl, F. U. in Mechanisms of Protein Folding (ed. Pain, R. H.) 2nd edn, 364\u2013405 (Oxford Univ. Press, Oxford, 1999)."},{"key":"BF416507a_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0896-6273(01)00177-5","volume":"29","author":"MY Sherman","year":"2001","unstructured":"Sherman, M. Y. & Goldberg, A. L. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron 29, 15\u201332 (2001).","journal-title":"Neuron"},{"key":"BF416507a_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1126\/science.287.5453.661","volume":"287","author":"LR Li","year":"2000","unstructured":"Li, L. R. & Lindquist, S. Creating a protein-based element of inheritance. Science 287, 661\u2013664 (2000).","journal-title":"Science"},{"key":"BF416507a_CR33","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/0092-8674(93)90259-S","volume":"73","author":"JW Booker","year":"1993","unstructured":"Booker, J. W. et al. Solution structure and ligand-binding site of the SH3 domain of the P85 alpha-subunit of phosphatidylinositil-3-kinase. Cell 73, 813\u2013822 (1993).","journal-title":"Cell"},{"key":"BF416507a_CR34","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/S0076-6879(99)09050-3","volume":"309","author":"DA Butterfield","year":"1999","unstructured":"Butterfield, D. A., Yatin, S. M., Varadarajan, S. & Koppal, T. Amyloid \u03b2-peptide-associated free radical oxidative stress, neurotoxicity and Alzheimer's disease. Methods Enzymol. 309, 746\u2013768 (1999).","journal-title":"Methods Enzymol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/416507a.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/416507a","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/416507a.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T20:28:23Z","timestamp":1684355303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/416507a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":34,"journal-issue":{"issue":"6880","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["BF416507a"],"URL":"https:\/\/doi.org\/10.1038\/416507a","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1007953.99707","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}